ATXI   $2.17  8.50% Market Closed After Close 2.1016 -3.15%

Avenue Therapeutics Inc
Total Cash 4.92M
totalCashPerShare 3.437
EBITDA
Total Debt 0.00
quickRatio 4.237
currentRatio 4.296
Total Revenue
debtToEquity
Revenue/Share
ROA -2.01345
ROE
grossProfits
freeCashflow -13.07M
operatingCashflow -8.59M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -2.86M
forwardPE -0.6766242
floatShares 1.29M
sharesOutstanding 1.43M
sharesShort 31.54K
sharesShortPriorMonth 36.65K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.08%
Short Ratio help_outline 1.14%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 4.004
Price To Book help_outline 0.53
earningsQuarterlyGrowth
netIncomeToCommon -14.68M
trailingEps 37.48%
forwardEps -3.14%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.94 3Q 2024
institutionsCount 9
lastUpdated Oct. 16, 2024, 6:57 p.m.